InMed Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
InMed Pharmaceuticals Inc share price today is $0.787, up -0.29%. The stock opened at $0.763 against the previous close of $0.82, with an intraday high of $0.831 and low of $0.7452.
InMed Pharmaceuticals Inc Share Price Chart
InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc Share Price Performance
InMed Pharmaceuticals Inc Institutional Holdings
InMed Pharmaceuticals Inc Market Status
InMed Pharmaceuticals Inc Fundamentals
Market Cap 2.39 M
PB Ratio 0.2489
PE Ratio 0.0
Enterprise Value -4.04 M
Total Assets 21.23 M
Volume 1212276
InMed Pharmaceuticals Inc Company Financials
About InMed Pharmaceuticals Inc & investment objective
Company Information InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Organisation Drug Manufacturers - Specialty & Generic
Employees 13
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Eric A. Adams B.S. Chem., M.I.B.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
InMed Pharmaceuticals Inc FAQs
What is the share price of InMed Pharmaceuticals Inc today?
The current share price of InMed Pharmaceuticals Inc is $0.787.
Can I buy InMed Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy InMed Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy InMed Pharmaceuticals Inc shares in India?
You can easily invest in InMed Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy InMed Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of InMed Pharmaceuticals Inc.
Can I buy fractional shares of InMed Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of InMed Pharmaceuticals Inc?
InMed Pharmaceuticals Inc has a market cap of $2.39 M.
In which sector does InMed Pharmaceuticals Inc belong?
InMed Pharmaceuticals Inc operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in InMed Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of InMed Pharmaceuticals Inc?
The PE ratio of InMed Pharmaceuticals Inc is N/A and the PB ratio is 0.25.